This study is not yet open for participant recruitment.
Verified by University of Pittsburgh, August 2010
Official Title
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting
Purpose
The investigators propose a randomized, open label trial of the immunogenicity of HPV vaccine among males 18-24 years old, comparing an on-time administration of the third dose with delayed administration of the third dose. All participants would receive the first and second doses according to schedule. They would be randomized to either Dose 3 at 6 months or Dose 3 at 12 months.
Hypothesis: The Geometric mean titers in the 12 month test group (T) are non-inferior to the usual timing control group (C):
View study details here.
